Auxilium Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

View All

Latest Posts

About This Stock More About This Stock
Can Pharma ETFs Continue Their Uptrend In 2015?
Article By: Zacks Investment Research
Sunday, January 11, 2015 12:42 PM EDT
The worst of the patent cliff is over for the pharma sector which is slowly but steadily recovering from the impact of genericization. The NYSE ARCA Pharmaceutical Index is up 19.3% over the last year.
In this article: PJP, XPH, IHE, PPH, JNJ, MRK, PFE, NVS, AVNR, AUXL, LLY, GILD, CELG
Read
How Corporate Inversion Opens A Whole New Can Of Worms
Article By: Dr. Hung Tran
Tuesday, September 23, 2014 4:24 PM EDT
Treasury Secretary Jacob Lew is pushing for tougher legislation to prevent companies from exercising corporate inversion to avoid US tax.
In this article: QLT, AUXL
Read
Endo Looking To Acquire Auxilium Pharmaceuticals For $2.2B
Article By: Zacks Investment Research
Wednesday, September 17, 2014 5:58 PM EDT
In a bid to expand its product portfolio/pipeline, Endo International submitted a proposal to take over Auxilium Pharmaceuticals for $2.2 billion in cash as well as stock. Endo intends to utilize its existing cash balance to fund the deal.
In this article: AUXL, ENDP
Read
Bring On The Orphans: Aegis Capital's Raghuram Selvaraju Lays Out A Winning Biotech Strategy
Article By: The Life Sciences Report
Thursday, August 14, 2014 6:48 AM EDT
For former drug researcher Raghuram "Ram" Selvaraju, picking biotech stocks is both science and art. It's about understanding the competitive landscape and the mechanisms of drug action, and then making sure all the pieces fit together for a plausible investment case.
In this article: AGN, AZN, GSK, JNJ, PFE, SNY, VRX, CUR, PLX, ACOR, ALXN, MDVN, SCLN, AUXL, ABBV
Read
All Posts

Latest Tweets for $AUXL

No tweets yet!

PARTNER HEADLINES